Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -42.56% is 38% above its 5-year average of -68.73%, near the high end of its 5-year range (-119.60%–-29.07%).
1.79% above its 12-month average of -43.34%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -48.12%.
OPERATING MARGIN
-42.56%
OPERATING MARGIN AVG TTM
-43.34%
OPERATING MARGIN AVG 3Y
-52.48%
OPERATING MARGIN AVG 5Y
-68.73%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+1.79%
CURRENT VS 3Y AVG
+18.91%
CURRENT VS 5Y AVG
+38.08%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
TELA Bio, Inc.
Market Cap
$48.99M
Operating Margin
-42.56%
TTM Avg
-43.34%
3Y Avg
-52.48%
5Y Avg
-68.73%
Market Cap
$49.06M
Operating Margin
-37.50%
TTM Avg
-9.07%
3Y Avg
3.39%
5Y Avg
-9.53%
Market Cap
$47.59M
Operating Margin
-111.45%
TTM Avg
-10696.13%
3Y Avg
-10482.04%
5Y Avg
-431164.93%
Market Cap
$48.76M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$49.71M
Operating Margin
-61738.00%
TTM Avg
-183136.86%
3Y Avg
-98100.06%
5Y Avg
-86611.75%
Market Cap
$49.58M
Operating Margin
-11.13%
TTM Avg
-20.11%
3Y Avg
-14.38%
5Y Avg
-12.43%
Market Cap
$49.45M
Operating Margin
-11541.50%
TTM Avg
-10608.91%
3Y Avg
-9412.76%
5Y Avg
-9062.71%
Market Cap
$51.99M
Operating Margin
N/A
TTM Avg
-19.41%
3Y Avg
-9.70%
5Y Avg
-6.47%
Market Cap
$47.98M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-13.26%
5Y Avg
-68.70%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| TELA Bio, Inc. (TELA) | $48.99M | -42.56% | -43.34% | -52.48% | -68.73% |
| Sensus Healthcare, Inc. (SRTS)vs › | $49.06M | -37.50% | -9.07% | 3.39% | -9.53% |
| Apollomics, Inc. (APLM)vs › | $47.59M | -111.45% | -10696.13% | -10482.04% | -431164.93% |
| Microbot Medical Inc. (MBOT)vs › | $48.76M | 0.00% | 0.00% | 0.00% | 0.00% |
| INmune Bio, Inc. (INMB)vs › | $49.71M | -61738.00% | -183136.86% | -98100.06% | -86611.75% |
| Precision Optics Corporation, Inc. (POCI)vs › | $49.58M | -11.13% | -20.11% | -14.38% | -12.43% |
| Clene Inc. (CLNN)vs › | $49.45M | -11541.50% | -10608.91% | -9412.76% | -9062.71% |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $51.99M | N/A | -19.41% | -9.70% | -6.47% |
| Lite Strategy, Inc. (LITS)vs › | $47.98M | 0.00% | 0.00% | -13.26% | -68.70% |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $52.13M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
67.8%
Operating Margin
-42.6%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -48.12% |
| 2026-03-31 | -55.23% |
| 2025-12-31 | -31.86% |
| 2025-09-30 | -36.51% |
| 2025-06-30 | -44.96% |
| 2025-03-31 | -56.54% |
| 2024-12-31 | -47.33% |
| 2024-09-30 | -49.40% |
| 2024-06-30 | -71.90% |
| 2024-03-31 | -29.07% |
| 2023-12-31 | -72.23% |
| 2023-09-30 | -67.64% |
| 2023-06-30 | -71.49% |
| 2023-03-31 | -94.50% |
| 2022-12-31 | -81.22% |
| 2022-09-30 | -85.02% |
| 2022-06-30 | -98.38% |
| 2022-03-31 | -119.60% |
| 2021-12-31 | -91.40% |
| 2021-09-30 | -94.29% |
| 2021-06-30 | -96.73% |
| 2021-03-31 | -123.69% |
| 2020-12-31 | -119.06% |
| 2020-09-30 | -129.17% |
| 2020-06-30 | -147.31% |
| 2020-03-31 | -174.42% |
| 2019-12-31 | -119.78% |
| 2019-09-30 | -97.06% |
| 2019-06-30 | -130.18% |
| 2019-03-31 | -156.68% |
| 2018-12-31 | -226.53% |
| 2018-09-30 | -114.10% |
| 2018-06-30 | -268.50% |
| 2018-03-31 | -268.50% |
